VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 23 filers reported holding VISTAGEN THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $2,880 | +21.1% | 23,097 | 0.0% | 0.00% | – |
Q4 2022 | $2,379 | -88.1% | 23,097 | 0.0% | 0.00% | -100.0% |
Q2 2022 | $20,000 | -31.0% | 23,097 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $29,000 | -35.6% | 23,097 | 0.0% | 0.00% | -33.3% |
Q4 2021 | $45,000 | -28.6% | 23,097 | 0.0% | 0.00% | -25.0% |
Q3 2021 | $63,000 | +28.6% | 23,097 | 0.0% | 0.00% | +33.3% |
Q1 2021 | $49,000 | +8.9% | 23,097 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $45,000 | +181.2% | 23,097 | 0.0% | 0.00% | +200.0% |
Q3 2020 | $16,000 | +33.3% | 23,097 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $12,000 | +20.0% | 23,097 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $10,000 | -37.5% | 23,097 | 0.0% | 0.00% | -50.0% |
Q4 2019 | $16,000 | -36.0% | 23,097 | 0.0% | 0.00% | -33.3% |
Q3 2019 | $25,000 | +47.1% | 23,097 | 0.0% | 0.00% | +50.0% |
Q2 2019 | $17,000 | -43.3% | 23,097 | 0.0% | 0.00% | -50.0% |
Q1 2019 | $30,000 | -14.3% | 23,097 | 0.0% | 0.00% | -20.0% |
Q4 2018 | $35,000 | +9.4% | 23,097 | 0.0% | 0.01% | +25.0% |
Q2 2018 | $32,000 | +52.4% | 23,097 | 0.0% | 0.00% | +33.3% |
Q1 2018 | $21,000 | – | 23,097 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACUTA CAPITAL PARTNERS, LLC | 11,728,033 | $36,943,000 | 14.76% |
VR Adviser, LLC | 16,047,286 | $50,549,000 | 6.13% |
COMMODORE CAPITAL LP | 3,331,315 | $10,494,000 | 3.66% |
Ghost Tree Capital, LLC | 2,000,000 | $6,300,000 | 1.73% |
EPIQ PARTNERS, LLC | 932,956 | $2,939,000 | 1.47% |
SPHERA FUNDS MANAGEMENT LTD. | 4,080,673 | $12,854,000 | 0.87% |
SILVERARC CAPITAL MANAGEMENT, LLC | 615,547 | $1,939,000 | 0.86% |
HighVista Strategies LLC | 308,096 | $971,000 | 0.69% |
NEA Management Company, LLC | 16,302,596 | $51,353,000 | 0.67% |
Nicholas Investment Partners, LP | 2,753,880 | $8,675,000 | 0.54% |